12:00 AM
Aug 27, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

ImmunoCellular management update

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Woodland Hills, Calif.
Business: Cancer

Read the full 29 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >